Wells Fargo’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.9M | Sell |
92,494
-55
| -0.1% | -$5.98K | ﹤0.01% | 1920 |
|
|
2026
Q1 | $8.55M | Sell |
92,549
-121,628
| -57% | -$12.2M | ﹤0.01% | 2164 |
|
|
2025
Q4 | $21.9M | Buy |
214,177
+100,192
| +88% | +$8.96M | ﹤0.01% | 1441 |
|
|
2025
Q3 | $7.12M | Sell |
113,985
-5,967
| -5% | -$325K | ﹤0.01% | 2289 |
|
|
2025
Q2 | $6.24M | Sell |
119,952
-57,052
| -32% | -$2.55M | ﹤0.01% | 2297 |
|
|
2025
Q1 | $7.54M | Buy |
177,004
+27,775
| +19% | +$1.2M | ﹤0.01% | 2093 |
|
|
2024
Q4 | $4.56M | Buy |
149,229
+90,240
| +153% | +$2.54M | ﹤0.01% | 2516 |
|
|
2024
Q3 | $1.35M | Sell |
58,989
-5,070
| -8% | -$143K | ﹤0.01% | 3344 |
|
|
2024
Q2 | $1.85M | Sell |
64,059
-17,580
| -22% | -$409K | ﹤0.01% | 3030 |
|
|
2024
Q1 | $1.68M | Sell |
81,639
-286,960
| -78% | -$6.15M | ﹤0.01% | 3112 |
|
|
2023
Q4 | $9.97M | Sell |
368,599
-54,226
| -13% | -$1.42M | ﹤0.01% | 1704 |
|
|
2023
Q3 | $12.5M | Sell |
422,825
-32,516
| -7% | -$1.14M | ﹤0.01% | 1402 |
|
|
2023
Q2 | $16.3M | Buy |
455,341
+84,185
| +23% | +$2.42M | ﹤0.01% | 1273 |
|
|
2023
Q1 | $8.7M | Buy |
371,156
+44,878
| +14% | +$1.28M | ﹤0.01% | 1695 |
|
|
2022
Q4 | $8.87M | Sell |
326,278
-62,704
| -16% | -$2.87M | ﹤0.01% | 1627 |
|
|
2022
Q3 | $20.9M | Buy |
388,982
+25,894
| +7% | +$1.33M | 0.01% | 1049 |
|
|
2022
Q2 | $14.6M | Sell |
363,088
-6,565
| -2% | -$325K | ﹤0.01% | 1323 |
|
|
2022
Q1 | $24.5M | Buy |
369,653
+9,404
| +3% | +$644K | 0.01% | 1179 |
|
|
2021
Q4 | $36M | Sell |
360,249
-968,192
| -73% | -$100M | 0.01% | 951 |
|
|
2021
Q3 | $166M | Sell |
1,328,441
-38,602
| -3% | -$4.59M | 0.04% | 451 |
|
|
2021
Q2 | $170M | Sell |
1,367,043
-48,528
| -3% | -$6.53M | 0.04% | 444 |
|
|
2021
Q1 | $216M | Buy |
1,415,571
+37,049
| +3% | +$5.6M | 0.05% | 376 |
|
|
2020
Q4 | $178M | Buy |
1,378,522
+125,153
| +10% | +$14.4M | 0.04% | 423 |
|
|
2020
Q3 | $140M | Buy |
1,253,369
+743,619
| +146% | +$68M | 0.04% | 427 |
|
|
2020
Q2 | $41.4M | Sell |
509,750
-36,274
| -7% | -$2.92M | 0.01% | 939 |
|
|
2020
Q1 | $38M | Buy |
546,024
+443,245
| +431% | +$34M | 0.01% | 903 |
|
|
2019
Q4 | $8.03M | Buy |
102,779
+43,723
| +74% | +$3.15M | ﹤0.01% | 2158 |
|
|
2019
Q3 | $3.77M | Buy |
59,056
+21,275
| +56% | +$1.87M | ﹤0.01% | 2795 |
|
|
2019
Q2 | $3.26M | Buy |
37,781
+31,115
| +467% | +$2.38M | ﹤0.01% | 2939 |
|
|
2019
Q1 | $511K | Sell |
6,666
-350,365
| -98% | -$19.4M | ﹤0.01% | 4317 |
|
|
2018
Q4 | $13.4M | Buy |
+357,031
| New | +$13.2M | ﹤0.01% | 1659 |
|
Other funds holding GH
DTC
Wells Fargo's GH Position: Q2 2026 in Review
Wells Fargo reduced its Guardant Health (GH) stake by 0.06% in Q2 2026, selling an estimated $5.98K and leaving 92,494 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1920.
Wells Fargo first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $216M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Wells Fargo held 92,494 shares of Guardant Health worth $13.9M as of Q2 2026.
- Wells Fargo sold 55 Guardant Health shares in Q2 2026, an estimated $5.98K.
- Guardant Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1920 holding.
- Wells Fargo first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- Wells Fargo's Guardant Health position peaked at $216M in Q1 2021.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.